1. A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. (January 2022) Authors: Plummer, Ruth; Dean, Emma; Arkenau, Hendrik-Tobias; Redfern, Charles; Spira, Alexander I.; Melear, Jason M.; Chung, Ki Y.; Ferrer-Playan, Jordi; Goddemeier, Thomas; Locatelli, Giuseppe; Dong, Jennifer; Fleuranceau-Morel, Patricia; Diaz-Padilla, Ivan; Shapiro, Geoffrey I. Journal: Lung cancer Issue: Volume 163(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 7 (July 2018) Authors: Clarke, Noel; Wiechno, Pawel; Alekseev, Boris; Sala, Nuria; Jones, Robert; Kocak, Ivo; Chiuri, Vincenzo Emanuele; Jassem, Jacek; Fléchon, Aude; Redfern, Charles; Goessl, Carsten; Burgents, Joseph; Kozarski, Robert; Hodgson, Darren; Learoyd, Maria; Saad, Fred Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 975 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial. Issue 10 (October 2022) Authors: Saad, Fred; Thiery-Vuillemin, Antoine; Wiechno, Pawel; Alekseev, Boris; Sala, Nuria; Jones, Robert; Kocak, Ivo; Chiuri, Vincenzo Emanuele; Jassem, Jacek; Fléchon, Aude; Redfern, Charles; Kang, Jinyu; Burgents, Joseph; Gresty, Christopher; Degboe, Arnold; Clarke, Noel W Journal: Lancet oncology Issue: Volume 23:Issue 10(2022) Page Start: 1297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study. Issue 6 (June 2019) Authors: Tamura, Kenji; Tsurutani, Junji; Takahashi, Shunji; Iwata, Hiroji; Krop, Ian E; Redfern, Charles; Sagara, Yasuaki; Doi, Toshihiko; Park, Haeseong; Murthy, Rashmi K; Redman, Rebecca A; Jikoh, Takahiro; Lee, Caleb; Sugihara, Masahiro; Shahidi, Javad; Yver, Antoine; Modi, Shanu Journal: Lancet oncology Issue: Volume 20:Issue 6(2019) Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗